Clinical Trial: Proteomics-Driven Predictive Modeling and Validation of Non-Response to Neoadjuvant Chemoimmunotherapy in Locally Advanced Gastric Cancer: A Multicenter Real-World Study (China)

Posted On: 2026-09-15

China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Proteomics-Driven Predictive Modeling and Validation of Non-Response to Neoadjuvant Chemoimmunotherapy in Locally Advanced Gastric Cancer: A Multicenter Real-World Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132417

Registration Time: 2026/09/14

Type: Diagnostic test

Primary Sponsor: The First Medical Center of Chinese PLA General Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342001

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Proteomics-Driven Predictive Modeling and Validation of Non-Response to Neoadjuvant Chemoimmunotherapy in Locally Advanced Gastric Cancer: A Multicenter Real-World Study (China)